Suppr超能文献

弗林蛋白酶对人解整合素和金属蛋白酶19(ADAM19)的细胞内激活通过两个连续识别位点之一发生。

Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites.

作者信息

Kang Tiebang, Zhao Yun-Ge, Pei Duanqing, Sucic Joseph F, Sang Qing-Xiang Amy

机构信息

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee 32306-4390, USA.

出版信息

J Biol Chem. 2002 Jul 12;277(28):25583-91. doi: 10.1074/jbc.M203532200. Epub 2002 May 2.

Abstract

Adamalysin 19 (a disintegrin and metalloproteinase 19, ADAM19, or meltrin beta) is a plasma membrane metalloproteinase. Human ADAM19 zymogen contains two potential furin recognition sites (RX(K/R)R), (196)KRPR(200)R and (199)RRMK(203)R, between its pro- and catalytic domains. Protein N-terminal sequencing revealed that the cellular mature forms of hADAM19 started at (204)EDLNSMK, demonstrating that the preferred furin cleavage site was the (200)RMK(203)R downward arrow(204)EDLN. Those mature forms were catalytically active. Both Pittsburgh mutant of alpha(1)-proteinase inhibitor and dec-Arg-Val-Lys-Arg-chloromethyl ketone, two specific furin inhibitors, blocked the activation of hADAM19. Activation of hADAM19 was also blocked by brefeldin A, which inhibits protein trafficking from the endoplasmic reticulum to the Golgi, or, a calcium ionophore known to inhibit the autoactivation of furin. When (202)KR were mutated to AA, the proenzyme was also activated, suggesting that (197)RPRR is an alternative activation site. Furthermore, only pro-forms of hADAM19 were detected in the (199)RR to AA mutant, which abolished both furin recognition sites. Moreover, the zymogens were not converted into their active forms in two furin-deficient mammalian cell lines; co-expression of hADAM19 and furin in these two cell lines restored zymogen activation. Finally, co-localization between furin and hADAM19 was identified in the endoplasmic reticulum-Golgi complex and/or the trans-Golgi network. This report is the first thorough investigation of the intracellular activation of adamalysin 19, demonstrating that furin activated pro-hADAM19 in the secretory pathway via one of the two consecutive furin recognition sites.

摘要

解整合素金属蛋白酶19(一种解整合素和金属蛋白酶19,ADAM19,或β-黑素瘤金属蛋白酶)是一种质膜金属蛋白酶。人ADAM19酶原在其前结构域和催化结构域之间含有两个潜在的弗林蛋白酶识别位点(RX(K/R)R),即(196)KRPR(200)R和(199)RRMK(203)R。蛋白质N端测序显示,hADAM19的细胞成熟形式起始于(204)EDLNSMK,表明首选的弗林蛋白酶切割位点是(200)RMK(203)R↓(204)EDLN。这些成熟形式具有催化活性。α1-蛋白酶抑制剂的匹兹堡突变体和两种特异性弗林蛋白酶抑制剂dec-Arg-Val-Lys-Arg-氯甲基酮均能阻断hADAM19的激活。布雷菲德菌素A也能阻断hADAM19的激活,布雷菲德菌素A可抑制蛋白质从内质网向高尔基体的转运,或者,一种已知可抑制弗林蛋白酶自身激活的钙离子载体也能阻断hADAM19的激活。当(202)KR突变为AA时,酶原也被激活,这表明(197)RPRR是一个替代激活位点。此外,在(199)RR突变为AA的突变体中只检测到hADAM19的前体形式,该突变消除了两个弗林蛋白酶识别位点。此外,在两种弗林蛋白酶缺陷的哺乳动物细胞系中,酶原未转化为其活性形式;在这两种细胞系中共同表达hADAM19和弗林蛋白酶可恢复酶原激活。最后,在内质网-高尔基体复合体和/或反式高尔基体网络中确定了弗林蛋白酶和hADAM19之间的共定位。本报告首次对解整合素金属蛋白酶19的细胞内激活进行了全面研究,证明弗林蛋白酶在分泌途径中通过两个连续的弗林蛋白酶识别位点之一激活前体hADAM19。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验